Article
TP53 mutations in prostatic cancer. Analysis of pre- and post-treatment archival formalin-fixed tumour tissue.
The Journal of pathology - 1 Jul 1995
Berner A, Geitvik G, Karlsen F, Fosså S D, Nesland J M, Børresen A L
Abstract excerpt
The TP53 gene mutation pattern in prostatic cancer was examined in relation to progression and survival, using archival formalin-fixed pre- and post-treatment tumour specimens from 84 prostatic cancer patients. Thirty-four had hormone-sensitive tumours and 50 were hormone-resistant. Six of the 34 (18 per cent) therapy-responding tumours and 19 of the 50 (38 per cent) hormone-resistant tumours showed p53 protein...
Topics
- Aged
- Aged, 80 and over
- Electrophoresis
- Formaldehyde
- Genes, p53
- Humans
- Male
- Middle Aged
- Mutation
- Prostatic Neoplasms
- Tissue Fixation
- Treatment Outcome
